2-[(2-Amino-6-methylpyrimidin-4-yl)sulfanyl]-N-arylacetamides: Discovery of a New Class of Anti-tubercular Agents and Prospects for Their Further Structural Modification.

[1]  F. J. Luque,et al.  Merging Ligand-Based and Structure-Based Methods in Drug Discovery: An Overview of Combined Virtual Screening Approaches , 2020, Molecules.

[2]  N. Voloshchuk,et al.  Synthesis, docking study, and pharmacological evaluation of S-acetamide derivatives of 4,6-dimethyl-2-thiopyrimidine as anticonvulsant agents , 2020 .

[3]  N. Voloshchuk,et al.  Design, synthesis, in vivo and in silico anticonvulsant activity studies of derivatives of 6-amino-4-hydroxy-2-thio-pyrimidine , 2020 .

[4]  Synthesis and anticonvulsant activity of 6-methyl-2-thioxo-2, 3-dihydropyrimidin-4(1H)-one acetamides , 2019, Journal of Applied Pharmaceutical Science.

[5]  Zahoor Ahmad,et al.  Cell wall: A versatile fountain of drug targets in Mycobacterium tuberculosis. , 2017, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[6]  E. De Clercq,et al.  Arylazolyl(azinyl)thioacetanilides. Part 20: Discovery of novel purinylthioacetanilides derivatives as potent HIV-1 NNRTIs via a structure-based bioisosterism approach. , 2016, Bioorganic & medicinal chemistry.

[7]  E. De Clercq,et al.  Arylazolyl(azinyl)thioacetanilides: Part 19 : Discovery of Novel Substituted Imidazo[4,5‐b]pyridin‐2‐ylthioacetanilides as Potent HIV NNRTIs Via a Structure‐based Bioisosterism Approach , 2016, Chemical biology & drug design.

[8]  A. Verkman,et al.  Synthesis and evaluation of 5,6-disubstituted thiopyrimidine aryl aminothiazoles as inhibitors of the calcium-activated chloride channel TMEM16A/Ano1 , 2016, Journal of enzyme inhibition and medicinal chemistry.

[9]  A. V. Erkin.  Aromatic aldehyde thiosemicarbazones in the synthesis of hydrazones of the pyrimidine series , 2015, Russian Journal of Organic Chemistry.

[10]  Peng Zhan,et al.  Arylazolyl(azinyl)thioacetanilides. Part 16: Structure-based bioisosterism design, synthesis and biological evaluation of novel pyrimidinylthioacetanilides as potent HIV-1 inhibitors. , 2014, Bioorganic & medicinal chemistry.

[11]  Vladimir Poroikov,et al.  Prediction of the Biological Activity Spectra of Organic Compounds Using the Pass Online Web Resource , 2014, Chemistry of Heterocyclic Compounds.

[12]  Peng Zhan,et al.  Heterocycle-thioacetic acid motif: a privileged molecular scaffold with potent, broad-ranging pharmacological activities. , 2013, Current pharmaceutical design.

[13]  Peng Zhan,et al.  Discovery of novel pyridazinylthioacetamides as potent HIV-1 NNRTIs using a structure-based bioisosterism approach , 2013 .

[14]  A. V. Erkin,et al.  Effect of the structural modification of 2-benzylamino-4-(4-iodophenyl)amino-6-methylpyrimidine on the biological activity of its derivatives , 2012, Russian Journal of General Chemistry.

[15]  Peng Zhan,et al.  Arylazolyl(azinyl)thioacetanilides. Part 10: design, synthesis and biological evaluation of novel substituted imidazopyridinylthioacetanilides as potent HIV-1 inhibitors. , 2012, Bioorganic & medicinal chemistry.

[16]  Robert Kiss,et al.  http://Mcule.com: a public web service for drug discovery , 2012, Journal of Cheminformatics.

[17]  G. V. Paolini,et al.  Quantifying the chemical beauty of drugs. , 2012, Nature chemistry.

[18]  E. De Clercq,et al.  Arylazolylthioacetanilide. Part 8: Design, synthesis and biological evaluation of novel 2-(2-(2,4-dichlorophenyl)-2H-1,2,4-triazol-3-ylthio)-N-arylacetamides as potent HIV-1 inhibitors. , 2011, European journal of medicinal chemistry.

[19]  J. Vekemans,et al.  Variable microwave effects in the synthesis of ureidopyrimidinones: the role of heterogeneity , 2011 .

[20]  C. Pannecouque,et al.  1,2,3‐Thiadiazole Thioacetanilides. Part 2 , 2010, Chemistry & biodiversity.

[21]  E. De Clercq,et al.  Synthesis and anti-HIV activity evaluation of 2-(4-(naphthalen-2-yl)-1,2,3-thiadiazol-5-ylthio)-N-acetamides as novel non-nucleoside HIV-1 reverse transcriptase inhibitors. , 2009, European journal of medicinal chemistry.

[22]  E. De Clercq,et al.  1,2,3-Selenadiazole thioacetanilides: synthesis and anti-HIV activity evaluation. , 2009, Bioorganic & medicinal chemistry.

[23]  Zengjun Fang,et al.  Synthesis and biological evaluation of imidazole thioacetanilides as novel non-nucleoside HIV-1 reverse transcriptase inhibitors. , 2009, Bioorganic & medicinal chemistry.

[24]  J. Duan,et al.  Thiotetrazole alkynylacetanilides as potent and bioavailable non-nucleoside inhibitors of the HIV-1 wild type and K103N/Y181C double mutant reverse transcriptases. , 2007, Bioorganic & medicinal chemistry letters.

[25]  M. Allan,et al.  Tri-substituted triazoles as potent non-nucleoside inhibitors of the HIV-1 reverse transcriptase. , 2006, Bioorganic & medicinal chemistry letters.

[26]  M. Rowley,et al.  Tetrazole thioacetanilides: potent non-nucleoside inhibitors of WT HIV reverse transcriptase and its K103N mutant. , 2006, Bioorganic & medicinal chemistry letters.

[27]  F. Lombardo,et al.  Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. , 2001, Advanced drug delivery reviews.

[28]  D. Shugar,et al.  High-Yield Regioselective Thiation of Biologically Important Pyrimidinones, Dihydropyrimidinones and Their Ribo, 2′-Deoxyribo and 2′, 3′-Dideoxyribo Nucleosides , 1993 .